Skip Navigation


JAC Advance Access originally published online on February 24, 2009
Journal of Antimicrobial Chemotherapy 2009 63(5):972-976; doi:10.1093/jac/dkp037
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
63/5/972    most recent
dkp037v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Citron, D. M.
Right arrow Articles by Goldstein, E. J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Citron, D. M.
Right arrow Articles by Goldstein, E. J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria

Diane M. Citron1,*, Yumi A. Warren1, Kerin L. Tyrrell1, Vreni Merriam1 and Ellie J. C. Goldstein1,2

1 R. M. Alden Research Laboratory, 6133 Bristol Parkway, Suite 175, Culver City, CA 90230, USA 2 Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA

Received 11 November 2008; returned 3 December 2008; revised 19 January 2009; accepted 21 January 2009

* Corresponding author. Tel: +1-310-641-8340; Fax: +1-310-641-8840; E-mail: d.m.citron{at}att.net

Objectives: The aim of this study was to determine the anaerobic spectrum of activity of REP3123, a novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria.

Methods: Fifty recent clinical isolates of Clostridium difficile from patients diagnosed with C. difficile infection and 223 other intestinal normal flora anaerobes were tested for their susceptibility to REP3123 and four or five comparator agents by the agar dilution method using supplemented Brucella agar with 5% laked sheep blood.

Results: All strains of C. difficile were inhibited by 0.5–1 mg/L REP3123, including those resistant to moxifloxacin and clindamycin. REP3123 lacked activity against many normal flora anaerobes in the gut, including Clostridium ramosum, bifidobacteria, lactobacilli of the Lactobacillus casei–rhamnosus–plantarum group and Gram-negative anaerobes.

Conclusions: REP3123 demonstrated good potency against C. difficile, but limited activity against many other intestinal anaerobic species, thus, in theory, maintaining the colonization resistance barrier.

Keywords: C. difficile infection , normal gut flora , colonization resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
U. A. Ochsner, S. J. Bell, A. L. O'Leary, T. Hoang, K. C. Stone, C. L. Young, I. A. Critchley, and N. Janjic
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model
J. Antimicrob. Chemother., May 1, 2009; 63(5): 964 - 971.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. A. Critchley, L. S. Green, C. L. Young, J. M. Bullard, R. J. Evans, M. Price, T. C. Jarvis, J. W. Guiles, N. Janjic, and U. A. Ochsner
Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections
J. Antimicrob. Chemother., May 1, 2009; 63(5): 954 - 963.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.